Search Results - "MIZUNO, YOSHIMI"

Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2 by Takimoto-Shimomura, Tomoko, Tsukamoto, Taku, Maegawa, Saori, Fujibayashi, Yuto, Matsumura-Kimoto, Yayoi, Mizuno, Yoshimi, Chinen, Yoshiaki, Shimura, Yuji, Mizutani, Shinsuke, Horiike, Shigeo, Taniwaki, Masafumi, Kobayashi, Tsutomu, Kuroda, Junya

“…Summary Despite the recent therapeutic progress, the prognoses of diffuse large B-cell lymphomas (DLBCLs) that concomitantly overexpress c-MYC and BCL2, i.e.,…”
Get full text

A novel method of amplified fluorescent in situ hybridization for detection of chromosomal microdeletions in B cell lymphoma by Mizuno, Yoshimi, Chinen, Yoshiaki, Tsukamoto, Taku, Takimoto-Shimomura, Tomoko, Matsumura-Kimoto, Yayoi, Fujibayashi, Yuto, Kuwahara-Ota, Saeko, Fujino, Takahiro, Nishiyama, Daichi, Shimura, Yuji, Kobayashi, Tsutomu, Horiike, Shigeo, Taniwaki, Masafumi, Kuroda, Junya

“…Chromosomal microdeletions frequently cause loss of prognostically relevant tumor suppressor genes in hematologic malignancies; however, detection of minute…”
Get full text

Burkitt Lymphoma Preceded by Autoimmune Hemolytic Anemia due to Anti-D Antibody by Mizuno, Yoshimi, Shimura, Yuji, Horiike, Shigeo, Takimoto, Tomoko, Maegawa, Saori, Tanba, Kazuna, Matsumura-Kimoto, Yayoi, Sumida, Yukari, Tatekawa, Shotaro, Tsukamoto, Taku, Chinen, Yoshiaki, Mizutani, Shinsuke, Nagoshi, Hisao, Yamamoto-Sugitani, Mio, Matsumoto, Yosuke, Kobayashi, Tsutomu, Kuroda, Junya, Taniwaki, Masafumi

“…We herein report a rare case of Burkitt lymphoma (BL) preceded by autoimmune hemolytic anemia (AIHA) caused by autoantibodies against D antigen. After a…”
Get full text

Chromosomal abnormality variation detected by G‐banding is associated with prognosis of diffuse large B‐cell lymphoma treated by R‐CHOP‐based therapy by Mizuno, Yoshimi, Tsukamoto, Taku, Kawata, Eri, Uoshima, Nobuhiko, Uchiyama, Hitoji, Yokota, Isao, Maegawa, Saori, Takimoto, Tomoko, Tanba, Kazuna, Matsumura‐Kimoto, Yayoi, Kuwahara‐Ota, Saeko, Fujibayashi, Yuto, Yamamoto‐Sugitani, Mio, Chinen, Yoshiaki, Shimura, Yuji, Horiike, Shigeo, Taniwaki, Masafumi, Kobayashi, Tsutomu, Kuroda, Junya

“…Diffuse large B‐cell lymphoma (DLBCL), which is the most prevalent disease subtype of non‐Hodgkin lymphoma, is highly heterogeneous in terms of cytogenetic and…”
Get full text

Lenalidomide and pomalidomide potently interfere with induction of myeloid‐derived suppressor cells in multiple myeloma by Kuwahara‐Ota, Saeko, Shimura, Yuji, Steinebach, Christian, Isa, Reiko, Yamaguchi, Junko, Nishiyama, Daichi, Fujibayashi, Yuto, Takimoto‐Shimomura, Tomoko, Mizuno, Yoshimi, Matsumura‐Kimoto, Yayoi, Tsukamoto, Taku, Chinen, Yoshiaki, Kobayashi, Tsutomu, Horiike, Shigeo, Taniwaki, Masafumi, Gütschow, Michael, Kuroda, Junya

“…Summary An increase in immunosuppressive myeloid‐derived suppressor cells (MDSCs) is associated with disease progression and treatment resistance in multiple…”
Get full text

Tumor-specific transcript variants of cyclin D1 in mantle cell lymphoma and multiple myeloma with chromosome 11q13 abnormalities by Chinen, Yoshiaki, Tsukamoto, Taku, Maegawa-Matsui, Saori, Matsumura-Kimoto, Yayoi, Takimoto-Shimomura, Tomoko, Tanba, Kazuna, Mizuno, Yoshimi, Fujibayashi, Yuto, Kuwahara-Ota, Saeko, Shimura, Yuji, Kobayashi, Tsutomu, Horiike, Shigeo, Taniwaki, Masafumi, Kuroda, Junya

“…•Mantle cell lymphoma and multiple myeloma with 11q13 abnormalities express Cyclin D1 transcript variants with longer 5′-UTRs.•Cyclin D1 transcript variants…”
Get full text

BRD4-Regulated Molecular Targets in Mantle Cell Lymphoma: Insights into Targeted Therapeutic Approach by TSUKAMOTO, TAKU, NAKAHATA, SHINGO, SATO, RYUICHI, KANAI, AKINORI, NAKANO, MASAKAZU, CHINEN, YOSHIAKI, MAEGAWA-MATSUI, SAORI, MATSUMURA-KIMOTO, YAYOI, TAKIMOTO-SHIMOMURA, TOMOKO, MIZUNO, YOSHIMI, KUWAHARA-OTA, SAEKO, KAWAJI, YUKA, TANIWAKI, MASAFUMI, INABA, TOSHIYA, TASHIRO, KEI, MORISHITA, KAZUHIRO, KURODA, JUNYA

“…Background: Since bromodomain-containing protein 4 (BRD4) facilitates the transcription of genes important for neoplastic cells in a cancer-type specific…”
Get full text

Clinicopathological significance of carbonic anhydrase 9, glucose transporter-1, Ki-67 and p53 expression in oral squamous cell carcinoma by KONDO, Yuhei, YOSHIKAWA, Kazuhiro, OMURA, Yukinobu, SHINOHARA, Atsushi, KAZAOKA, Yoshiaki, SANO, Junji, MIZUNO, Yoshimi, YOKOI, Toyoharu, YAMADA, Shiro

“…Carbonic anhydrase 9 (CA9) is a glycoprotein present on the surface of cell membranes. It is expressed in 90% of renal cancer cells, but not in normal kidney…”
Get full text

Establishment and Characteristics of a Novel Mantle Cell Lymphoma-derived Cell Line and a Bendamustine-resistant Subline by Takimoto-Shimomura, Tomoko, Nagoshi, Hisao, Maegawa, Saori, Fujibayashi, Yuto, Tsukamoto, Taku, Matsumura-Kimoto, Yayoi, Mizuno, Yoshimi, Chinen, Yoshiaki, Mizutani, Shinsuke, Shimura, Yuji, Horiike, Shigeo, Taniwaki, Masafumi, Kobayashi, Tsutomu, Kuroda, Junya

“…Background/Aim: Bendamustine hydrochloride (BH) is a key therapeutic agent for mantle cell lymphoma (MCL), while the mechanism underlying BH-resistance has not…”
Get full text

Prediction of delayed platelet engraftment after autologous stem cell transplantation for B-cell non-Hodgkin lymphoma by Yamaguchi, Junko, Chinen, Yoshiaki, Takimoto-Shimomura, Tomoko, Nagata, Hiroaki, Muramatsu, Ayako, Kuriyama, Kodai, Ohshiro, Muneo, Hirakawa, Yoshiko, Iwai, Toshiki, Uchiyama, Hitoji, Uoshima, Nobuhiko, Kaneko, Hiroto, Nakao, Mitsushige, Tsukamoto, Taku, Shimura, Yuji, Kobayashi, Tsutomu, Horiike, Shigeo, Yokota, Isao, Kuroda, Junya

“…Delayed platelet engraftment (DPE) is occasionally observed despite prompt neutrophil engraftment after autologous peripheral blood stem cell transplantation…”
Get full text

Phosphoinositide-dependent protein kinase 1 is a potential novel therapeutic target in mantle cell lymphoma by Maegawa, Saori, Chinen, Yoshiaki, Shimura, Yuji, Tanba, Kazuna, Takimoto, Tomoko, Mizuno, Yoshimi, Matsumura-Kimoto, Yayoi, Kuwahara-Ota, Saeko, Tsukamoto, Taku, Kobayashi, Tsutomu, Horiike, Shigeo, Taniwaki, Masafumi, Kuroda, Junya

“…•3-Phosphoinositide-dependent protein kinase 1 (PDPK1) is found to be constitutively activated in various types of patient-derived B-cell non-Hodgkin lymphoma…”
Get full text

Intravenous bortezomib for multiple myeloma that has progressed after subcutaneous bortezomib therapy by Kuroda, Junya, Mizutani, Shinsuke, Shimura, Yuji, Maegawa, Saori, Nagoshi, Hisao, Chinen, Yoshiaki, Tatekawa, Shotaro, Tsukamoto, Taku, Mizuno, Yoshimi, Yamamoto-Sugitani, Mio, Kobayashi, Tsutomu, Matsumoto, Yosuke, Horiike, Shigeo, Taniwaki, Masafumi

Get full text

Human herpesvirus-6 pneumonitis in a patient with follicular lymphoma following immunochemotherapy with rituximab by Kuwahara-Ota, Saeko, Chinen, Yoshiaki, Mizuno, Yoshimi, Takimoto-Shimomura, Tomoko, Matsumura-Kimoto, Yayoi, Tanba, Kazuna, Tsukamoto, Taku, Mizutani, Shinsuke, Shimura, Yuji, Kobayashi, Tsutomu, Horiike, Shigeo, Kuroda, Junya

“…Primary infection with human herpesvirus-6 (HHV-6) commonly occurs at an early age in children, most often at 3 years of age, and is associated with childhood…”
Get full text

Human herpesvirus-6 pneumonitis in a patient with follicular lymphoma following immunochemotherapy with rituximab by Kuwahara-Ota, Saeko, Chinen, Yoshiaki, Mizuno, Yoshimi, Takimoto-Shimomura, Tomoko, Matsumura-Kimoto, Yayoi, Tanba, Kazuna, Tsukamoto, Taku, Mizutani, Shinsuke, Shimura, Yuji, Kobayashi, Tsutomu, Horiike, Shigeo, Kuroda, Junya

Get full text

Intravenous bortezomib for multiple myeloma that has progressed after subcutaneous bortezomib therapy by Kuroda, Junya, Mizutani, Shinsuke, Shimura, Yuji, Maegawa, Saori, Nagoshi, Hisao, Chinen, Yoshiaki, Tatekawa, Shotaro, Tsukamoto, Taku, Mizuno, Yoshimi, Yamamoto-Sugitani, Mio, Kobayashi, Tsutomu, Matsumoto, Yosuke, Horiike, Shigeo, Taniwaki, Masafumi

Get full text